Vyloy 100 mg

Vyloy 100 mg is a medicine authorised by Swissmedic under authorisation number 69501. The authorisation holder is Astellas Pharma AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 19 February 2025 and the authorisation is limited until 18 February 2030. ATC code L01FX31 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 69501
  • ATC L01FX31
  • Biotechnological medicines
Authorisation data
Authorisation number69501
NameVyloy 100 mg
Full nameVyloy 100 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Authorisation holderAstellas Pharma AG
Medicinal product codeBiotechnological medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01FX31
First authorisation19 February 2025
Authorisation validity18 February 2030
Strengths
No.NameDispensing categoryAuthorisation date
1Vyloy 100 mg, Pulver für ein Konzentrat zur Herstellung einer InfusionslösungA19 February 2025
2Vyloy 300 mg, Pulver für ein Konzentrat zur Herstellung einer InfusionslösungA22 January 2026

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)L01FX3107.16.1.A
23Durchstechflasche(n)L01FX3107.16.1.A
31Durchstechflasche(n)L01FX3107.16.1.A

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Vyloy 100 mg authorised in Switzerland?

Yes. Vyloy 100 mg is authorised by Swissmedic under authorisation number 69501, data as of 01 September 2026. The authorisation is limited until 18 February 2030.

Which dispensing category does Vyloy 100 mg have?

Vyloy 100 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Vyloy 100 mg?

The authorisation holder is Astellas Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com